BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Heart
,
Avian flu virus
,
Lovastatin
,
rs2476601
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
AMA1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hypoxia
Effects of heat
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Citrinin
ochratoxin A
Ethylmaleimide
Plant Extracts
fusarenon-X
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RAD23
XKS1
NAB2
CSTF3
SNF1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Knockout and functional analysis of BSSS-related genes in Acremonium chrysogenum by novel episomal e…
Structure-based design of a strain transcending AMA1-RON2L malaria vaccine.
Characterization of AMA1-RON2L complex with native gel electrophoresis and capillary isoelectric foc…
The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts.
cAMP-dependent protein kinase regulates secretion of apical membrane antigen 1 (AMA1) in Plasmodium …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of AdCh63 AMA1 Alone and With MVA AMA1
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7…
Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA M…
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ